Cutaneous complications after transcatheter arterial treatment for hepat ocellular carcinoma via the internal mammary artery : how to avoid this complication
Cutaneous complications after transcatheter arterial treatment for hepat ocellular carcinoma via the internal mammary artery : how to avoid this complication
复制标题
经乳内动脉经导管动脉治疗肝眼细胞癌后的皮肤并发症:如何避免这种并发症
DOI:
10.1007/s11604-011-0559-9
复制
发表时间:
2011
期刊:
影响因子:
2.1
通讯作者:
Awai K
中科院分区:
文献类型:
--
作者:
Kajiwara K;Kakizawa H;Takeuchi N;Toyota N;Hieda M;Ishikawa M;Tanitame K;Tani G;Suzuki T;Fujikawa K;Aikata H;Chayama K;Awai K
PurposeTo lower the rate of cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma (HCC) via the internal mammary artery (IMA) we retrospectively assessed the complications.Materials and methodsWe reviewed cutaneous complications in 14 patients with 18 HCCs who had undergone 17 treatment procedures via the IMA, including selective transcatheter arterial infusion chemotherapy with Lipiodol (Lip-TAI) (n= 3), selective Lip-TAI + transcatheter arterial embolization (TAE) (n= 3), nonselective Lip-TAI (n= 1), nonselective Lip-TAI + TAE (n= 5), and nonselective TAE (n= 5). The filling and nonfilling of subcutaneous vessels with Lipiodol was examined on postoperative computed tomography (CT) scans.ResultsSkin rash (n= 3) and ulceration (n= 1) occurred after 4 of 17 (24%) procedures: two of three selective Lip-TAI procedures and two of five nonselective Lip-TAI + TAE procedures. The doses of chemotherapeutic agents for tumor sizes in selective Lip-TAI procedures were higher than those in selective Lip-TAI + TAE procedures. Cutaneous complications were encountered after two of three procedures with filling but not after any of eight procedures without filling.ConclusionA lower dose of chemotherapeutic agents may be less risky when undertaking a selective procedure via the IMA for HCC. If nonselective, TAE alone may be less risky. Postoperative CT may be helpful for predicting cutaneous complications.